Therefore, tumor-intrinsic inflammatory signaling not only overcomes the senescence barrier that hinders transformation of pre-malignant, KRAS-mutated cells, but is also a critical mechanism through which KRAS-mutant cells subvert the external stromal and immune cells. The gene discussed is KRAS; the disease is neoplasm.